Huangming Hong
8PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 28, 2025
ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.Jing Ding, Xia Zou, Xuefeng Huang
|Feb 20, 2024
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.Zegeng Chen, He Huang, Huageng Huang
|Nov 24, 2023
Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.Huawei Weng, Prem Raj Shrestha, Huangming Hong
|Jun 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.Jing Quan Lim, Dachuan Huang, Jason Yongsheng Chan
|Jun 26, 2020
Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2- Advanced Breast Cancer.Ning Xie, Tao Qin, Wei Ren
|Apr 02, 2020
A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy.Sio Teng Lam, He Huang, Xiaojie Fang
Pageof 2
Frequent Collaborators
2 joint publications
Zegeng Chen
1 joint publications
Zhao Wang
1 joint publications
Jing Quan Lim
1 joint publications
Yi-Jiun Su
1 joint publications
Qing-Qing Cai
1 joint publications
Siok-Bian Ng
1 joint publications
Kia Joo Puan
1 joint publications
Wei-Li Zhao
1 joint publications
Huawei Weng
1 joint publications
Huilai Zhang
